Asuragen develops Armored RNA Quant SARS-CoV-2 control in Industry News Create PDFApril 16, 2020—Asuragen has developed an Armored RNA Quant SARS-CoV-2 Control for use in developing assays in response to the COVID-19 pandemic. Pages: 1 2 Asuragen 2020-04-16 CAP TODAY Previous Post Next Post
CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
